Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia

Kiran Musunuru, James P. Pirruccello, Ron Do, Gina M. Peloso, Candace Guiducci, Carrie Sougnez, Kiran V. Garimella, Sheila Fisher, Justin Abreu, Andrew J. Barry, Tim Fennell, Eric Banks, Lauren Ambrogio, Kristian Cibulskis, Andrew Kernytsky, Elena Gonzalez, Nicholas Rudzicz, James C. Engert, Mark A. DePristo, Mark J. Daly & 7 others Jonathan C. Cohen, Helen H. Hobbs, David Altshuler, Gustav Schonfeld, Stacey B. Gabriel, Pin Yue, Sekar Kathiresan

Research output: Contribution to journalArticle

324 Citations (Scopus)

Abstract

We sequenced all protein-coding regions of the genome (the "exome") in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders. (Funded by the National Human Genome Research Institute and others.)

Original languageEnglish (US)
Pages (from-to)2220-2227
Number of pages8
JournalNew England Journal of Medicine
Volume363
Issue number23
DOIs
StatePublished - Dec 2 2010

Fingerprint

Angiopoietins
Exome
LDL Cholesterol
HDL Cholesterol
Mutation
National Human Genome Research Institute (U.S.)
Proteins
Lipoprotein Lipase
Nonsense Codon
Heterozygote
Lipase
Open Reading Frames
Rodentia
Triglycerides
Genome
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Musunuru, K., Pirruccello, J. P., Do, R., Peloso, G. M., Guiducci, C., Sougnez, C., ... Kathiresan, S. (2010). Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. New England Journal of Medicine, 363(23), 2220-2227. https://doi.org/10.1056/NEJMoa1002926

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. / Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Peloso, Gina M.; Guiducci, Candace; Sougnez, Carrie; Garimella, Kiran V.; Fisher, Sheila; Abreu, Justin; Barry, Andrew J.; Fennell, Tim; Banks, Eric; Ambrogio, Lauren; Cibulskis, Kristian; Kernytsky, Andrew; Gonzalez, Elena; Rudzicz, Nicholas; Engert, James C.; DePristo, Mark A.; Daly, Mark J.; Cohen, Jonathan C.; Hobbs, Helen H.; Altshuler, David; Schonfeld, Gustav; Gabriel, Stacey B.; Yue, Pin; Kathiresan, Sekar.

In: New England Journal of Medicine, Vol. 363, No. 23, 02.12.2010, p. 2220-2227.

Research output: Contribution to journalArticle

Musunuru, K, Pirruccello, JP, Do, R, Peloso, GM, Guiducci, C, Sougnez, C, Garimella, KV, Fisher, S, Abreu, J, Barry, AJ, Fennell, T, Banks, E, Ambrogio, L, Cibulskis, K, Kernytsky, A, Gonzalez, E, Rudzicz, N, Engert, JC, DePristo, MA, Daly, MJ, Cohen, JC, Hobbs, HH, Altshuler, D, Schonfeld, G, Gabriel, SB, Yue, P & Kathiresan, S 2010, 'Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia', New England Journal of Medicine, vol. 363, no. 23, pp. 2220-2227. https://doi.org/10.1056/NEJMoa1002926
Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. New England Journal of Medicine. 2010 Dec 2;363(23):2220-2227. https://doi.org/10.1056/NEJMoa1002926
Musunuru, Kiran ; Pirruccello, James P. ; Do, Ron ; Peloso, Gina M. ; Guiducci, Candace ; Sougnez, Carrie ; Garimella, Kiran V. ; Fisher, Sheila ; Abreu, Justin ; Barry, Andrew J. ; Fennell, Tim ; Banks, Eric ; Ambrogio, Lauren ; Cibulskis, Kristian ; Kernytsky, Andrew ; Gonzalez, Elena ; Rudzicz, Nicholas ; Engert, James C. ; DePristo, Mark A. ; Daly, Mark J. ; Cohen, Jonathan C. ; Hobbs, Helen H. ; Altshuler, David ; Schonfeld, Gustav ; Gabriel, Stacey B. ; Yue, Pin ; Kathiresan, Sekar. / Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. In: New England Journal of Medicine. 2010 ; Vol. 363, No. 23. pp. 2220-2227.
@article{c4eabb4ab1f140bd8c41e7da55a47645,
title = "Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia",
abstract = "We sequenced all protein-coding regions of the genome (the {"}exome{"}) in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders. (Funded by the National Human Genome Research Institute and others.)",
author = "Kiran Musunuru and Pirruccello, {James P.} and Ron Do and Peloso, {Gina M.} and Candace Guiducci and Carrie Sougnez and Garimella, {Kiran V.} and Sheila Fisher and Justin Abreu and Barry, {Andrew J.} and Tim Fennell and Eric Banks and Lauren Ambrogio and Kristian Cibulskis and Andrew Kernytsky and Elena Gonzalez and Nicholas Rudzicz and Engert, {James C.} and DePristo, {Mark A.} and Daly, {Mark J.} and Cohen, {Jonathan C.} and Hobbs, {Helen H.} and David Altshuler and Gustav Schonfeld and Gabriel, {Stacey B.} and Pin Yue and Sekar Kathiresan",
year = "2010",
month = "12",
day = "2",
doi = "10.1056/NEJMoa1002926",
language = "English (US)",
volume = "363",
pages = "2220--2227",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "23",

}

TY - JOUR

T1 - Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia

AU - Musunuru, Kiran

AU - Pirruccello, James P.

AU - Do, Ron

AU - Peloso, Gina M.

AU - Guiducci, Candace

AU - Sougnez, Carrie

AU - Garimella, Kiran V.

AU - Fisher, Sheila

AU - Abreu, Justin

AU - Barry, Andrew J.

AU - Fennell, Tim

AU - Banks, Eric

AU - Ambrogio, Lauren

AU - Cibulskis, Kristian

AU - Kernytsky, Andrew

AU - Gonzalez, Elena

AU - Rudzicz, Nicholas

AU - Engert, James C.

AU - DePristo, Mark A.

AU - Daly, Mark J.

AU - Cohen, Jonathan C.

AU - Hobbs, Helen H.

AU - Altshuler, David

AU - Schonfeld, Gustav

AU - Gabriel, Stacey B.

AU - Yue, Pin

AU - Kathiresan, Sekar

PY - 2010/12/2

Y1 - 2010/12/2

N2 - We sequenced all protein-coding regions of the genome (the "exome") in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders. (Funded by the National Human Genome Research Institute and others.)

AB - We sequenced all protein-coding regions of the genome (the "exome") in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders. (Funded by the National Human Genome Research Institute and others.)

UR - http://www.scopus.com/inward/record.url?scp=78649755576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649755576&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa1002926

DO - 10.1056/NEJMoa1002926

M3 - Article

VL - 363

SP - 2220

EP - 2227

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 23

ER -